Innoviva
INVA
200 hedge funds and large institutions have $1.09B invested in Innoviva in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 27 closing their positions.
29% more call options, than puts
Call options by funds: $6.02M | Put options by funds: $4.66M
17% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 66
7% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 27
0% more funds holding
Funds holding: 200 → 200 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $1.14B → $1.09B (-$55.8M)
3.12% less ownership
Funds ownership: 74.01% → 70.89% (-3.1%)
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$29.7M |
| 2 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
-$13.8M |
| 3 |
GL
GLG LLC
New York
|
-$11.6M |
| 4 |
First Eagle Investment Management
New York
|
-$8.46M |
| 5 |
Millennium Management
New York
|
-$8.31M |
INVA Hedge Fund Activity: Q4 2017 in Review
200 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2017, worth a combined $1.09B — down 4.9% from $1.14B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new INVA positions and 27 closed out — a net gain of 2 holders — while 77 added to existing stakes and 66 trimmed.
The largest buyer was Connor, Clark & Lunn Investment Management (CC&L), adding an estimated $9.46M. The largest seller was Fidelity Investments, cutting an estimated $29.7M.
- 200 institutional investors held Innoviva (INVA) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $1.09B of Innoviva stock for Q4 2017, down 4.9% quarter-over-quarter.
- 29 funds opened new Innoviva positions in Q4 2017 and 27 closed out, a net change of +2 holders.
- The largest Innoviva buyer in Q4 2017 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $9.46M added.
- The largest Innoviva seller in Q4 2017 was Fidelity Investments, an estimated $29.7M sold.
Based on aggregated 13F filings for Q4 2017.